Stay updated with the latest healthcare market news, including major mergers, stock movers, and policy updates.

NASHVILLE, TENNESSEE / ACCESS Newswire / November 20, 2025 / CenExel, a leading network of clinical research sites, is hosting a two-day Good Clinical Practice (GCP) training initiative beginning ...

Pertussis is one of the top 10 leading causes of death worldwide and remains a concern in the U.S. despite vaccination ...

Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...

Want a COVID-19 vaccination this fall? For many Americans, it's not clear how easy it will be to get one. A vial of Moderna ...

Moderna (MRNA) announced it has closed a five-year term loan facility for up to $1.5B of capital from Ares Management Credit Funds to increase ...

Moderna ($MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year ...

A scattering of S&P 500 companies have yet to report third quarter results, with most of the reports in the rearview mirror.

A bipartisan report warned Congress about China’s growing control over the pharmaceutical supply chain. Elsewhere, Alkermes sweetened its bid for Avadel and Moderna is investing $140 million in U.S.

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

The UK is launching a groundbreaking Horizon trial to see if a vaccine can help people with multiple sclerosis by targeting ...